ask our doctors

Myelodysplastic Syndrome

Get the facts on Myelodysplastic Syndrome treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Myelodysplastic Syndrome prevention, screening, research, statistics and other Myelodysplastic Syndrome related topics. We answer all your qestions about Myelodysplastic Syndrome.

Question: What is the difference between Myelodysplastic syndrome and chronic myeloid leukemia?

Answer: Myelodysplastic syndromes are bone marrow stem cell disorders that cause inefficient blood production. CML is unregulated growth of myeloid cells in the bone marrow and the accumulation of these cells in the blood. It is also a marrow stem cell disorder.


Myelodysplastic Syndrome News

kypost.com

Markey receives $6.25 million to study deadly cancer
The Lane Report
 

Onconova Advances Oral Rigosertib to Phase II Clinical Trial in ...

MarketWatch (press release)
The intravenous (IV) formulation of rigosertib is currently in a pivotal Phase III trial for refractory myelodysplastic syndromes (MDS) in the US and EU. "A randomized Phase II evaluation of oral rigosertib will be conducted in patients with Low or ...
 

UK cancer center gets grants to study blood and bone marrow disease

The Courier-Journal
Myelodysplastic syndrome, or MDS, affects the way the body produces blood cells. Once it develops, it can progress into leukemia, and it is largely untreatable. A major risk factor for MDS is past exposure to chemo or radiation, particularly for the ...
 

The Star-Ledger - NJ.com

Fairleigh Dickinson University president resigns due to illness
The Star-Ledger - NJ.com
 

The Star-Ledger - NJ.com

Citing illness, FDU president to step down
Dailyrecord.com
 

Bio-Path Holdings Reports First Quarter 2012 Operational and Financial Results

MarketWatch (press release)
... product candidate, BP-100-1.01 (Liposomal Grb-2), which is a systemic treatment for blood cancers including acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), acute lymphoblastic leukemia (ALL) and myelodysplastic syndrome (MDS).
 

Plasma protein alterations in the refractory anemia with excess blasts subtype ...

7thSpace Interactive (press release)
Refractory anemia with excess blasts subtype 1 (RAEB-1) is a subgroup of myelodysplastic syndrome. It represents a heterogeneous group of oncohematological bone marrow diseases, which occur particularly in elderly patients. The aim of this proteomic ...
 

Former York City Detective Dies in Florida

PennLive.com
Unlike thousands of people suffering from myelodysplastic syndrome, a compatible bone-marrow donor had been found for him. He felt he could beat the potentially fatal stem-cell disease that used to be called pre-leukemia. But further testing determined ...
 

Cyclacel to Report New Sapacitabine Clinical Data at the American Society of ...

MarketWatch (press release)
Sapacitabine oral capsules is in the SEAMLESS Phase 3 trial being conducted under an SPA with the FDA as front-line treatment of acute myeloid leukemia (AML) in the elderly, Phase 2 studies for AML, myelodysplastic syndromes (MDS), solid tumors ...
 

Telik Announces the Publication of Two Reports in the Journal Of Hematology ...

NEWS.GNOM.ES (press release)
The first is ?Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS),? Raza, A., et al., Journal of Hematology & Oncology 2012 ...